Genyro Announces New Paper Demonstrating How Sidewinder Technology Democratizes DNA Construction at Scale and Facilitates AI-Driven Protein DesignSAN FRANCISCO, May 04, 2026 (GLOBE NEWSWIRE) -- Genyro, a San Diego-based biotechnology company advancing next-generation DNA construction, announced significant new data just published on bioRxiv that will be discussed at SynBioBeta in San Francisco. The data details new developments in Genyro’s breakthrough DNA construction invention, Sidewinder, recently published in Nature, which achieves first-of-its-kind realization of scalable, parallel DNA construction that overcomes the cost, time, and accuracy constraints of existing methods and opens the door to scalable AI-facilitated DNA design.
Genyro Signs Exclusive License for “Sidewinder,” a Breakthrough DNA Construction Technology Featured in NatureA major technological advance in DNA writing enables researchers to construct and create in the language of biology
